These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24082107)

  • 1. Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway.
    Apcher S; Millot G; Daskalogianni C; Scherl A; Manoury B; Fåhraeus R
    Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17951-6. PubMed ID: 24082107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioneer translation products as an alternative source for MHC-I antigenic peptides.
    Apcher S; Daskalogianni C; Fåhraeus R
    Mol Immunol; 2015 Dec; 68(2 Pt A):68-71. PubMed ID: 25979818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear processing of nascent transcripts determines synthesis of full-length proteins and antigenic peptides.
    Martins RP; Malbert-Colas L; Lista MJ; Daskalogianni C; Apcher S; Pla M; Findakly S; Blondel M; Fåhraeus R
    Nucleic Acids Res; 2019 Apr; 47(6):3086-3100. PubMed ID: 30624716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.
    Apcher S; Daskalogianni C; Manoury B; Fåhraeus R
    PLoS Pathog; 2010 Oct; 6(10):e1001151. PubMed ID: 20976201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic peptides: Reviving nuclear translation.
    Van Damme P; Menschaert G
    Nat Chem Biol; 2013 Dec; 9(12):759-60. PubMed ID: 24231616
    [No Abstract]   [Full Text] [Related]  

  • 6. A distinct translation initiation mechanism generates cryptic peptides for immune surveillance.
    Starck SR; Ow Y; Jiang V; Tokuyama M; Rivera M; Qi X; Roberts RW; Shastri N
    PLoS One; 2008; 3(10):e3460. PubMed ID: 18941630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation.
    Apcher S; Daskalogianni C; Lejeune F; Manoury B; Imhoos G; Heslop L; Fåhraeus R
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11572-7. PubMed ID: 21709220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear translation for immunosurveillance.
    Yewdell JW; David A
    Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17612-3. PubMed ID: 24143809
    [No Abstract]   [Full Text] [Related]  

  • 9. Major histocompatibility class I antigenic peptides derived from translation of pre-mRNAs generate immune tolerance.
    Sroka EM; Lavigne M; Pla M; Daskalogianni C; Tovar-Fernandez MC; Prado Martins R; Manoury B; Darrasse-Jéze G; Nascimento M; Apcher S; Fåhraeus R
    Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2208509120. PubMed ID: 36745791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class I antigen presentation of DRiP-derived peptides from a model antigen is not dependent on the AAA ATPase p97.
    Palmer AL; Dolan BP
    PLoS One; 2013; 8(7):e67796. PubMed ID: 23844095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of mRNA translation in direct MHC class I antigen presentation.
    Apcher S; Manoury B; Fåhraeus R
    Curr Opin Immunol; 2012 Feb; 24(1):71-6. PubMed ID: 22341517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage.
    Lupetti R; Pisarra P; Verrecchia A; Farina C; Nicolini G; Anichini A; Bordignon C; Sensi M; Parmiani G; Traversari C
    J Exp Med; 1998 Sep; 188(6):1005-16. PubMed ID: 9743519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA translation from an antigen presentation perspective: A tribute to the works of Nilabh Shastri.
    Apcher S; Tovar-Fernadez M; Ducellier S; Thermou A; Nascimento M; Sroka E; Fahraeus R
    Mol Immunol; 2022 Jan; 141():305-308. PubMed ID: 34920325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus.
    Powers CJ; Früh K
    PLoS Pathog; 2008 Oct; 4(10):e1000150. PubMed ID: 18833297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAs.
    Yang N; Gibbs JS; Hickman HD; Reynoso GV; Ghosh AK; Bennink JR; Yewdell JW
    J Immunol; 2016 May; 196(9):3608-17. PubMed ID: 27016602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis of MHC class I antigenic peptides in the nucleus: a role for the nuclear translation at last?].
    Duvallet E; Boulpicante M; Apcher S
    Med Sci (Paris); 2014 Mar; 30(3):229-31. PubMed ID: 24685205
    [No Abstract]   [Full Text] [Related]  

  • 17. MHC-I presentation of peptides derived from intact protein products of the pioneer round of translation.
    Weinstein-Marom H; Hendel L; Laron EA; Sharabi-Nov A; Margalit A; Gross G
    FASEB J; 2019 Oct; 33(10):11458-11468. PubMed ID: 31343935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-conventional sources of peptides presented by MHC class I.
    Starck SR; Shastri N
    Cell Mol Life Sci; 2011 May; 68(9):1471-9. PubMed ID: 21390547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?
    Yewdell JW; Antón LC; Bennink JR
    J Immunol; 1996 Sep; 157(5):1823-6. PubMed ID: 8757297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PYM binds the cytoplasmic exon-junction complex and ribosomes to enhance translation of spliced mRNAs.
    Diem MD; Chan CC; Younis I; Dreyfuss G
    Nat Struct Mol Biol; 2007 Dec; 14(12):1173-9. PubMed ID: 18026120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.